Biochemicals and Reagents

Amylase antibody is a polyclonal antibody that specifically targets and binds to amylase, an enzyme responsible for the breakdown of starch into sugars. This antibody has been widely used in life sciences research to study the role of amylase in various biological processes.

A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS9 antibody, catalog no. 70R-5743

The NR4A1 antibody is a monoclonal antibody that targets the cholinergic receptor NR4A1. It has been extensively studied in the field of Life Sciences and has shown promising results in various assays. This antibody has been found to be effective in inhibiting the activity of NR4A1, which plays a crucial role in thrombocytopenia and other related conditions. The NR4A1 antibody works by binding to the receptor and blocking its function, leading to a decrease in platelet production. In addition, this antibody has also been used in research studies involving histidine and epidermal growth factor, further highlighting its versatility. With its cytotoxic properties and ability to inhibit choline acetyltransferase, the NR4A1 antibody holds great potential for therapeutic applications. It is available as both a monoclonal and polyclonal antibody, making it suitable for various research needs.

ELISA Kit for detection of IL12 (p70) in the research laboratory

DDX27 antibody was raised in Rabbit using Human DDX27 as the immunogen

Eptazocine is a peptide that belongs to the group of activators. It is used as a research tool in cell biology, pharmacology, and other life science fields. Eptazocine has been shown to inhibit the activity of ion channels and receptors. Furthermore, it has been used as an antibody to study protein interactions. Eptazocine can be used as a reagent for studying ligand-receptor interactions and is a member of the opioid receptor family. It binds to alpha-subunits of opioid receptors, which are G protein-coupled receptors that activate phospholipase C and inhibit adenylyl cyclase.

A synthetic peptide for use as a blocking control in assays to test for specificity of PLXDC1 antibody, catalog no. 70R-4608

Purified Polyclonal PPP4R1L antibody

Troxipide is a gastric cytoprotective agent that is used for the treatment of gastroesophageal reflux disease (GERD). It has anti-inflammatory, anti-ulcer and mucus secreting properties. This drug inhibits proinflammatory mediators in order to restore the normal gastric mucosa.

The PPM1B antibody is a monoclonal antibody that targets the phosphatase enzyme PPM1B. It has been extensively studied in the field of Life Sciences and has shown promising results in various applications. This antibody specifically recognizes and binds to PPM1B, inhibiting its activity and preventing its interaction with other molecules.

MTHFD2 antibody was raised using a synthetic peptide corresponding to a region with amino acids LPLPEHIDERRICNAVSPDKDVDGFHVINVGRMCLDQYSMLPATPWGVWE

A synthetic peptide for use as a blocking control in assays to test for specificity of Gal3st4 antibody, catalog no. 70R-8834

Elopiprazole is a 5-HT1A receptor antagonist that has been shown to be effective in the treatment of psychosis and depression. It is a prodrug that is converted into elopiprant in the body by esterases, which inhibits H3 acetylation and thereby prevents transcription of inflammatory bowel disease. Elopiprazole has been shown to have no effect on 5-ht2a receptors, dopamine receptors, or histone h3 acetylation. The drug also has a molecular structure similar to the active form of clozapine (clozapine N-oxide), which is known for its high affinity for dopamine receptors. This may explain why elopiprazole has anti-psychotic effects.

Biased agonist of ?-opioid receptor ?OR; anti-pain agent with reduced addictivity

1-260 amino acids: MSHHWGYGKH NGPEHWHKDF PIAKGERQSP VDIDTHTAKY DPSLKPLSVS YDQATSLRIL NNGHAFNVEF DDSQDKAVLK GGPLDGTYRL IQFHFHWGSL DGQGSEHTVD KKKYAAELHL VHWNTKYGDF GKAVQQPDGL AVLGIFLKVG SAKPGLQKVV DVLDSIKTKG KSADFTNFDP RGLLPESLDY WTYPGSLTTP PLLECVTWIV LKEPISVSSE QVLKFRKLNF NGEGEPEELM VDNWRPAQPL KNRQIKASFK

Myxochelin A is an iron-chelating siderophore, which is a specialized secondary metabolite produced by certain strains of myxobacteria. These microorganisms, often found in soil and decomposing material, synthesize Myxochelin A to scavenge iron from the environment, essential for their survival and growth. The mode of action of Myxochelin A involves the sequestration of ferric iron (Fe^3+) ions through its high-affinity binding sites. This effectively deprives competing microorganisms of the iron required for crucial biological processes, imparting an antimicrobial effect.

OTS514 is a polymeric molecule that has been shown to have tumor-suppressive and anti-proliferative effects in cancer cells. OTS514 is able to induce autophagy, a process of cellular self-digestion that eliminates the abnormal cell mTOR protein. This drug also inhibits the expression of the leukocyte antigen (HLA) and blocks the G1/S phase transition. OTS514 can be used for treating patients with cervical cancer and other cancers. In vitro studies have shown that OTS514 induces apoptosis in cancer cells by inhibiting proteasome activity and inducing caspase activation. It also inhibits the growth factor epidermal growth factor, which leads to reduced angiogenesis and tumor progression.

TBCD antibody was raised in rabbit using the N terminal of TBCD as the immunogen

A synthetic peptide for use as a blocking control in assays to test for specificity of TYRP1 antibody, catalog no. 70R-7374

ELISA Kit for detection of Mouse Coagulation Factor III in the research laboratory